In a multicenter, cross-sectional epidemiological Lp(a)HERITAGE study to evaluate the incidence of elevated Lp(a) in patients with known ASCVD (post-myocardial infarction, ischemic stroke or PAD), nearly 90% of the obtained Lp(a) results were not known before enrolment (24). This evidence concerns the gene LPA and peripheral arterial disease.